# Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome

> **NCT02789488** · PHASE4 · COMPLETED · sponsor: **Chemical Resources** · enrollment: 50 (actual)

## Conditions studied

- Poly Cystic Ovary Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Fenugreek seeds extract 500 mg

## Key facts

- **NCT ID:** NCT02789488
- **Lead sponsor:** Chemical Resources
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02789488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02789488, "Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02789488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*